News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
Avigen, Inc. Stops Development of Lead Drug; Reduces Headcount by 70%
December 22, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dec 22 (Reuters) - Biopharmaceutical company Avigen Inc said it would stop all clinical trials of its experimental treatment for spasticity related to multiple sclerosis, which failed a mid-stage trial in October.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
MORE ON THIS TOPIC
Layoff Tracker
Alector Nearly Halves Workforce Following Dementia Drug Phase III Failure
October 23, 2025
·
74 min read
·
BioSpace Editorial Staff
Job Trends
8 Companies Hiring Now in Regulatory
October 23, 2025
·
2 min read
·
Angela Gabriel
Job Trends
Posers and Pretenders: Interview Fraud Rising, Experts Say
October 23, 2025
·
5 min read
·
Angela Gabriel
Job Trends
Most Employers Consider Hiring but Worry About Overqualified Job Candidates: Survey
October 22, 2025
·
3 min read
·
Angela Gabriel
